Maze Therapeutics, Inc. · NASDAQ:MAZE
Maze Therapeutics, Inc. shareholders
As of Jun 30, 2026, 155 institutions reported holding Maze Therapeutics, Inc. Largest: Frazier Life Sciences Management, L.P., Trv Gp IV, LLC and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Maze Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 5.03M | +466K | Aug 14, 2026 | |
| Trv Gp IV, LLC | 4.47M | no change | Aug 10, 2026 | |
| ARCH Venture Management, LLC | 4.12M | no change | Aug 14, 2026 | |
| Deep Track Capital, LP | 3.73M | +255K | Aug 14, 2026 | |
| BlackRock | 3.5M | +932K | Aug 7, 2026 | |
| Jupiter Topco LLC | 3.41M | first report | Aug 14, 2026 | |
| T. Rowe Price | 2.74M | +2.61M | Aug 14, 2026 | |
| Vanguard | 2.42M | +627K | Aug 13, 2026 | |
| Logos Global Management LP | 1.94M | +700K | Aug 14, 2026 | |
| a16z Capital Management, L.L.C. | 1.7M | no change | Aug 14, 2026 |